Background and objective: Desferrioxamine injection
is a method of treatment for iron overloaded
thalassemic patients, recommended by subcutaneous
injection. Currently using retained Butterfly needle
into subcutaneous, causing pain and dissatisfaction,
therefore it was changed to retained IV Catheter into
subcutaneous.The purpose of this research was to
evaluate the effectiveness of Desferrioxamine
administration by Retained IV Catheter into
Subcutaneous towards pain and Satisfaction in
Thalassemic Patients.
Methods: This investigation was a Quasiexperimental
research, one group pretest – posttest
design.Selected by purposive sampling focused on 30
inclusion criteria patients.The research tool were 1) A
pain assessment 2) A satisfaction assessment.Data was
analyzed by using frequency, percentage,means,
standard deviation,and Paired t-test.
Results: The results showed that using
Desferrioxamine injection by retained IV-Catheter into
subcutaneous, patients had overall pain at the level
of no pain (0.40±0.81). While retained butterfly needle
into subcutaneous, the patients had moderate pain (5.40±1.19). Comparison the pain of both injection
methods, it was found that there were statistically
significant differences (p<0.001). Whereas the
satisfaction of Desferrioxamine injection by retained
IV-Catheter into subcutaneous is the highest level
(4.40±0.50), while the butterfly needle was at a
moderate level (2.87±0.35) and found that satisfaction
with both methods has statistically significant
differences (p<0.001).
Conclusion: An iron chelotor, Desferrioxamine
injection by retained IV-Catheter into subcutaneous,
thalassemic patients had less pain and more
satisfaction than retained butterfly needle into
subcutaneous.
Keywords
Thalassemi a Desferri oxami ne Butterfly-needle IV-Catheter Subcutaneous injection